Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.

@article{Woo2010PrevalenceAC,
  title={Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.},
  author={K. -S. Woo and Kyung-eun Kim and Jeong man Kim and Jin Yeong Han and W T Chung and Kyeong Hee Kim},
  journal={The Korean journal of laboratory medicine},
  year={2010},
  volume={30 1},
  pages={38-44}
}
BACKGROUND The presence of antiphospholipid antibodies (aPLs) is associated with the clinical features of antiphospholipid syndrome (APS), which comprises venous and arterial thrombosis and pregnancy loss, and systemic lupus erythematosus (SLE). The prevalence of aPLs has been reported to be different in patient populations affected by either of these conditions. We performed a retrospective study to evaluate the prevalence and clinical associations of aPLs, including lupus anticoagulant (LAC… CONTINUE READING

Similar Papers

Loading similar papers…